MedStar Health News

The first clinical trial to compare standard of care chemotherapy with molecularly tailored therapy (also known as precision medicine) for metastatic pancreatic cancer is now enrolling patients at Georgetown Lombardi Comprehensive Cancer Center.

“The vests are an investment in the safety and security of our dogs,” said MedStar Union Memorial Hospital’s Corporal Joel Schindler.

Barbara S. Bregman, PhD, senior research scientist and director of education and training with MedStar NRH Research Division, and a professor in the Departments of Neuroscience and Rehabilitation Medicine at Georgetown University Medical Center and the Center for Brain Plasticity at Georgetown University, is the recipient of the 28th Annual John W. Goldschmidt Award.

New Facility Unlocks New Model of Care and Patient Experience Washington, D.C., June 14, 2016 – The first dedicated heart and vascular hospital in the nation’s capital is opening on the campus of...

Three physicians from the MedStar Georgetown Transplant Institute traveled to the White House today for the Obama Administration’s Organ Summit aimed at setting new strategies to increase access to organ transplants and shorten the organ waiting list.

The Diabetes Self-Management Program celebrates 17 years of helping people live well with diabetes. What causes diabetes? Can people with diabetes eat dessert? Is it true that healthy foods won...